Endometrial Cancer Research and Education Act of 2025

This bill aims to fight endometrial cancer by boosting research and public education. It highlights that this cancer is the fourth most common cancer in women, mostly affecting those ages 55 to 64. It notes growing cases and worse outcomes for African-American women, and says the reasons for these gaps are still unclear, with researchers looking at delays in care, later diagnoses, and access to treatment as possible factors.

Key points

• Who is affected: Women nationwide, especially African-American women; patients, families, doctors, and researchers.
• What changes:
  • NIH must expand and coordinate endometrial cancer research, share new findings and diagnosis disparities with medical professionals, and ensure African-American women are represented in clinical trials in proportion to how often they get the disease.
  • CDC must create and share easy-to-understand materials on rates, risks, higher risk for some minority women, and treatment options, with materials tailored for African-American women; CDC will consult with HRSA on this work.
• Funding and timing:
  • NIH: authorizes $1,000,000 each year for 2026–2028 to carry out these research and communication duties.
  • CDC: authorizes “such sums as necessary” for 2026–2028 to develop and share public information.